On the one hand, in keratinocytes, ascorbate (100 M) reduces the level of Nrf2 inhibitor, i.e., Keap1 protein, and increases free Nrf2 expression, as well as its activators, including p62 and KAP1, on the other [33,83]
(2019) 124 Suppl 1:S4552
My Protocol: Retatrutide 6 mg weekly (after 12-week escalation) + KLOW 2.5 mg daily subcutaneous View Product Understanding the Retatrutide + KLOW Combination What is KLOW
PubMed: (peer-reviewed) Wang X, et al
5 Nasal Application of Insulin Improves Cognition and Pathological Markers of AD To test the hypothesis that improving insulin signaling in the brain will show improvements in patients with AD, Suzanne Craft and colleagues conducted a series of experiments where patients with MCI or AD were treated with insulin
Follow the dosing schedule provided by your clinician, as protocols often start low and increase gradually to improve tolerability